Furthermore, SFN reduced the viability and telomerase activity of hepatocellular carcinoma Hep3B cells by activating ROS‐dependent pathway signaling and reducing microtubule polymerization (Moon et al., 2010; Pocasap et al., 2018). The gene discussed is SFN; the disease is hepatocellular carcinoma.